GMCL1 and cancer: Interestingly, we found that several cancer types (e.g.: endometrial, breast, and upper aerodigestive tract cancers) with high levels of GMCL1 mRNA exhibited resistance to paclitaxel, cabazitaxel, and/or docetaxel (Figure 3A–C).